David Tamblyn

Research Interests

Translational Health Outcomes Epidemiology Health Economics Health Policy Public Health

Mr David Tamblyn

Lecturer

School of Public Health

College of Health

Mr David Tamblyn is the Manager at Adelaide Health Technology Assessment (AHTA) in the School of Public Health, Adelaide University. He has worked in the field of health technology assessment for over 15 years, and has experience evaluating pharmaceuticals, devices and medical services. He has been involved in HTA evaluations for both reimbursement and regulatory purposes, and in the development of national guidelines to inform the assessment of pharmaceuticals and medical services.Mr Tamblyn's qualifications include a Masters of Public Health, University of Adelaide and Bachelor of Health Sciences, University of Adelaide. Mr Tamblyn is a Course Coordinator and Lecturer in the Master of Public Health Program, teaching into Public Health Evaluation and Economics and Health Technology Assessment. He is a committee member of the South Australian Policy Advisory Committee for Technology (SAPACT), and a committee member of the South Australian Medicines Evaluation Panel (SAMEP). Mr Tamblyn is currently the Chair of the HTA Glossary English Editorial Board.

Date Position Institution name
2026 - ongoing Course Coordinator Adelaide University
2026 - ongoing Lecturer Adelaide University
2023 - 2025 Course Coordinator Adelaide University
2022 - 2025 Lecturer University of Adelaide
2021 - ongoing Manager Adelaide University
2015 - 2021 Team Leader Adelaide University
2010 - 2015 Senior Research Officer Adelaide University
2005 - 2011 Clinical Data Manager SA Health

Date Institution name Country Title
University of Adelaide Australia Bachelor
University of Adelaide Australia Masters

Year Citation
2025 Carter, D., HASSAN, M., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2025). Engaging stakeholders along health technology assessment pathways: A scoping review of international practice. International Journal of Technology Assessment in Health Care, 41(1), e69-1-e69-9.
DOI Scopus2 WoS2
2022 Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., . . . Molsen, E. (2022). Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. European Journal of Health Economics, 23(8), 1309-1317.
DOI Scopus26 Europe PMC19
2015 Leach, D., Need, E., Toivanen, R., Trotta, A., Palenthorpe, H., Tamblyn, D., . . . Buchanan, G. (2015). Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome. Oncotarget, 6(18), 16135-16150.
DOI Scopus70 WoS63 Europe PMC62
2015 Leach, D. A., Need, E. F., Toivanen, R., Trotta, A. P., Palenthorpe, H. M., Tamblyn, D. J., . . . Buchanan, G. (2015). Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome [Oncotarget. 2015; 6:16135-16150]. Oncotarget, 6(34), 36923.
DOI Scopus4 WoS2 Europe PMC2
2014 Merlin, T., Tamblyn, D., Ellery, B., & NAHTA Quality Assurance Group. (2014). What's in a name? developing definitions for common health technology assessment product types of the international network of agencies for health technology assessment (Inahta). International Journal of Technology Assessment in Health Care, 30(4), 430-437.
DOI Scopus36 WoS35 Europe PMC30
2011 Tamblyn, D., Chopra, S., Yu, C., Kattan, M., Pinnock, C., & Kopsaftis, T. (2011). Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. BJU International, 108(Suppl 2), 51-57.
DOI Scopus19 WoS18 Europe PMC13
2009 Beckmann, K., Pinnock, C., Tamblyn, D., Kopsaftis, T., Stapleton, A., & Roder, D. (2009). Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort. Asia Pacific Journal of Clinical Oncology, 2009(5), 247-256.
DOI Scopus13 WoS12
2008 Stapleton, A., Johns, R., Kopsaftis, T., & Tamblyn, D. (2008). Abnormal PSA tests: delays in referral. Australian Family Physician, 37(1-2), 84-88.
Scopus8 WoS8 Europe PMC4

Year Citation
2009 Beckmann, K., Pinnock, C. B., Tamblyn, D. J., Kopsaftis, T., Stapleton, A. M. F., & Roder, D. (2009). Prostate cancer in South Australia: equitable access but later presentation. In BJU INTERNATIONAL Vol. 103 (pp. 11-12). Gold Coast, AUSTRALIA: WILEY-BLACKWELL PUBLISHING, INC.

Year Citation
2015 Vogan, A., Mitchell, A., Tamblyn, D., & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway.
2013 Moshi, M. R., Tamblyn, D., & Merlin, T. (2013). Rise of Co-dependent Technologies: Surveying Stakeholders’ about their opinion on the co-dependent technology framework and decision-making process [Poster]. Poster session presented at the meeting of SA State Population Health Conference. Adelaide, South Australia.
2013 Merlin, T. L., Ellery, B., Juneja, V., & Tamblyn, D. (2013). What’s in a name? - Mapping the different HTA products of INAHTA members. Poster session presented at the meeting of the 10th Annual Meeting Health Technology Assessment international (HTAi). Seoul, South Korea.

Year Citation
2024 Laka, M., Carter, D., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2024). International health technology market approval, funding and assessment pathways (1). Canberra: Commonwealth of Australia.
2024 Tamblyn, D., Morona, J., Carter, D., Kessels, S., & Merlin, T. (2024). Clinical Evaluation Methods in HTA (4). Canberra: Commonwealth of Australia.
2024 Merlin, T., Laka, M., Carter, D., Gao, Y., Choi, Y. -S., Parsons, J., . . . Tamblyn, D. (2024). Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning. Canberra, ACT: Commonwealth of Australia.
DOI WoS13
2024 Parsons, J., Milverton, J., Ellery, B., Tamblyn, D., & Merlin, T. (2024). Horizon scanning and early assessment: Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (2). Canberra, ACT: Commonwealth of Australia.
2024 Newton, S., Hill, H., Tamblyn, D., & Merlin, T. (2024). HTA Methods: Determination of Population, Intervention, Comparator, and Outcome (PICO): Health Technology Assessment Policy and Methods Review: HTA Pathways and Processes, Clinical Evaluation Methods and Horizon Scanning (3). Canberra, ACT: Commonwealth of Australia.
2022 Milverton, J., Demir, M., Carter, D., Hill, H., Parsons, J., Tamblyn, D., & Vogan, A. (2022). Genetic testing for children with hearing impairment (MSAC Application 1680). Canberra: Commonwealth of Australia.
2022 Kessels, S., Mittal, R., Newton, S., & Tamblyn, D. (2022). Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia (MSAC FFP review 1697). Canberra: Commonwealth of Australia.
2020 Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Technical report to supplement clinical utility card for genetic testing for diagnosis of inheritable cardiomyopathies (MSAC Application 1599). Canberra: Commonwealth of Australia.
2020 Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Clinical utility card for heritable cardiomyopathies.
2016 Tamblyn, D., Schubert, C., & Merlin, T. L. (2016). Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. Commonwealth of Australia.
2012 Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia.

Year Citation
2015 Authors: Morona J, Tamblyn D, Ellery B, Merlin T. Title: National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Description: N/A. Extent: N/A.
2011 Authors: Fitridge R, Templeton S, Buckley E, Docter S, Morona J, Reddin E, Juneja V, Merlin T. Title: National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes. Description: N/A. Extent: N/A.

Mr Tamblyn has taught into the University of Adelaide bachelor of medicine and surgery, and into both undergraduate and post-graduate public health. Topics covered include health economics, evaluation methods and epidemiology.

Date Role Board name Institution name Country
2025 - ongoing Chair English Editorial Board, International HTA Glossary Health Technology Assessment International (HTAi) / International Network of Agencies for Health Technology Assessment (INAHTA) Australia

Date Institution Department Organisation Type Country
2021 - ongoing South Australian Medicines Evaluation Panel (SAMEP) SA Health Health services and related Australia
2018 - 2023 National Health and Medical Research Council National Health and Medical Research Council Health services and related Australia
2018 - ongoing South Australian Policy Advisory Committee on Technology (SAPACT) SA Health Health services and related Australia
2018 - 2024 TGA Breast Implant Expert Working Group Therapeutics Goods Administration Health services and related Australia

Date Topic Presented at Institution Country
2017 - 2017 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Evaluator Workshop Canberra AHTA, presenting at request of Australian Government Department of Health Australia
2016 - 2016 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review Submission Sponsor Workshop Sydney (3), Melbourne (2) AHTA, presenting at request of Australian Government Department of Health Australia

Date Title Type Institution Country
2017 - ongoing - - International Journal for Technology Assessment in Health Care United Kingdom

Connect With Me

External Profiles

Other Links